BCTXBriaCell Therapeutics Corp.

BCTX Stock Price, Valuation & Chart | BriaCell Therapeutics Corp.

Compare

$3.570-0.06 (-1.65%)

At close · 02 Sept 2026, 08:00 pm

Sector: Healthcare Industry: Biotechnology BCTX intrinsic value BCTX calculated fair value vs price

Overview Financials Dividends Ratios

BCTX Historical price chart

BCTX Key Stats

Fair Value

Disclaimer

Disclaimer: This fair value estimate is for informational purposes only and should not be considered as investment advice. Fair value calculations are based on DCF (Discounted Cash Flow), P/E Multiple, and P/S Multiple models and assumptions that may not reflect actual market conditions. Always conduct your own research and consult with a financial advisor before making investment decisions.

Unlock

Market Capitalization31.06M

PE Ratio-0.19

EPS-18.41

Trading Volume94.45K

Today's High/Low3.76/3.57

Dividend Yield0.00

52 Week High/Low14.68/2.6

Shares Outstanding8.70M

BCTX Financial Statement

BCTX Analyst ratings

BCTX Analysis & performance metrics

BCTX Company profile

BriaCell Therapeutics Corp., an immuno-oncology biotechnology company, engages in developing immunotherapies for the treatment of cancer. Its lead candidate is Bria-IMT that…

BriaCell Therapeutics Corp., an immuno-oncology biotechnology company, engages in developing immunotherapies for the treatment of cancer. Its lead candidate is Bria-IMT that is in Phase I/IIa clinical trial in a combination study with immune checkpoint inhibitors for the treatment of breast cancer. The company also has a cooperative research and development agreement with the National…

BCTX Management team

Name

Position

Gadi Levin B.Com., C.A., CPA, M.B.A.CFO

Chief Financial Officer & Corporate Secretary

Charles Louis Wiseman FACP, M.D.

Founder, Principal Research Advisor & Member of Scientific Advisory Board

William V. Williams FCPA, M.D.CEO

Chief Executive Officer, President & Director

Miguel A. Lopez-Lago Ph.D.

Chief Scientific Officer

Giuseppe Del Priore M.D., M.P.H., MPH

Chief Medical Officer

Name

Position

Gadi Levin B.Com., C.A., CPA, M.B.A.CFO

Chief Financial Officer & Corporate Secretary

Charles Louis Wiseman FACP, M.D.

Founder, Principal Research Advisor & Member of Scientific Advisory Board

William V. Williams FCPA, M.D.CEO

Chief Executive Officer, President & Director

Miguel A. Lopez-Lago Ph.D.

Chief Scientific Officer

Giuseppe Del Priore M.D., M.P.H., MPH

Chief Medical Officer

Management Team

Gadi Levin B.Com., C.A., CPA, M.B.A.CFO

Chief Financial Officer & Corporate Secretary

Charles Louis Wiseman FACP, M.D.

Founder, Principal Research Advisor & Member of Scientific Advisory Board

William V. Williams FCPA, M.D.CEO

Chief Executive Officer, President & Director

Miguel A. Lopez-Lago Ph.D.

Chief Scientific Officer

Giuseppe Del Priore M.D., M.P.H., MPH

Chief Medical Officer

Management

Gadi Levin B.Com., C.A., CPA, M.B.A.CFO

Chief Financial Officer & Corporate Secretary

Charles Louis Wiseman FACP, M.D.

Founder, Principal Research Advisor & Member of Scientific Advisory Board

William V. Williams FCPA, M.D.CEO

Chief Executive Officer, President & Director

Miguel A. Lopez-Lago Ph.D.

Chief Scientific Officer

Giuseppe Del Priore M.D., M.P.H., MPH

Chief Medical Officer

Total 5 executives

BCTX Frequently asked questions

What is BriaCell Therapeutics Corp. (BCTX) Stock Price?

Current stock price of BriaCell Therapeutics Corp. (BCTX) stock is $3.570. The stock price is -1.65% lower in the session. The intraday range can be seen from this page. Volume of BriaCell Therapeutics Corp. (BCTX) stock is 94.45K.

Last updated at 02 Sept 2026, 08:00 pm.

Why is the BriaCell Therapeutics Corp. (BCTX) stock price going up or down today?

The stock price of BriaCell Therapeutics Corp. (BCTX) can change with earnings, company news, and overall market sentiment. BriaCell Therapeutics Corp. operates in the Healthcare / Biotechnology market, so sector-wide moves can also affect the share price. Use the live price, percentage change, and volume on this page to judge whether a move looks meaningful.

Is the BriaCell Therapeutics Corp. stock expensive at its current price?

Whether BriaCell Therapeutics Corp. looks expensive depends on valuation metrics versus its growth outlook. The P/E ratio shown for BCTX on this page is -0.19. EPS on this page is -18.41. Compare those figures with peers and growth expectations before deciding if the current BriaCell Therapeutics Corp. price is justified.

How has the stock price of BriaCell Therapeutics Corp. (BCTX) performed historically?

Historical performance for BriaCell Therapeutics Corp. (BCTX) is shown on the price chart on this page. Review multi-period moves alongside volume to see how BCTX reacted to past earnings and market events.

Should I buy BriaCell Therapeutics Corp. (BCTX) stock, at this price?

Buying BriaCell Therapeutics Corp. (BCTX) depends on your risk tolerance, time horizon, and portfolio needs. As a Healthcare name, weigh the live quote, key stats, and valuation links on this page rather than a single price point.